GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)

SHA:600771 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	342.93	116.67	259.97	246.4	145.15	393.67
Cash & Short-Term Investments	342.93	116.67	259.97	246.4	145.15	393.67
Cash Growth	104.69%	-55.12%	5.51%	69.76%	-63.13%	65.18%
Accounts Receivable	516.72	439.13	830.73	1,033	1,460	1,863
Other Receivables	2.18	10.83	1.66	56.53	143.34	148.7
Receivables	518.9	449.96	832.39	1,089	1,603	2,011
Inventory	664.8	766.95	569.53	415.04	352.9	362.67
Other Current Assets	45.57	33.83	20.33	13.15	24.07	43.73
Total Current Assets	1,572	1,367	1,682	1,764	2,125	2,811
Property, Plant & Equipment	643.49	663.48	707.24	710.26	738.37	769.75
Long-Term Investments	16.5	16.57	25.89	32.89	53.89	54.07
Other Intangible Assets	93.84	96.09	93.75	98.54	96.13	100.3
Long-Term Deferred Tax Assets	91.88	95.93	91.69	73.69	61.29	36.87
Long-Term Deferred Charges	3.47	3.79	4.34	6.16	12.37	9.89
Other Long-Term Assets	32.6	32.61	23.28	15.32	15.37	15.71
Total Assets	2,454	2,276	2,628	2,701	3,102	3,798
Accounts Payable	48.16	60.27	56.41	263.87	489.08	785.34
Accrued Expenses	402.24	373.13	508.35	419.04	54.25	57.95
Short-Term Debt	30.14	19.95	56.06	165	245.86	299.8
Current Portion of Long-Term Debt	-	-	189.86	62.2	12	10
Current Portion of Leases	8.27	8.19	6.33	1.93	-	-
Current Income Taxes Payable	1.72	2.17	0.71	-	1.42	1.37
Current Unearned Revenue	36.76	50.83	69.02	38.78	20.25	24.64
Other Current Liabilities	203.42	119.16	156.82	106.49	50.62	92.97
Total Current Liabilities	730.71	633.7	1,044	1,057	873.49	1,272
Long-Term Debt	-	-	-	197.6	70	26
Long-Term Leases	29.01	33.79	39.11	6.2	-	-
Long-Term Unearned Revenue	22.66	15.27	15.1	13.63	15.35	17.82
Long-Term Deferred Tax Liabilities	2.5	2.4	13.51	2.7	2.81	2.43
Other Long-Term Liabilities	-	-	9.27	-	-	10
Total Liabilities	784.88	685.17	1,121	1,277	961.65	1,328
Common Stock	489.49	489.49	489.49	489.49	492	492
Additional Paid-In Capital	1,588	1,588	1,588	1,588	1,637	1,637
Retained Earnings	-427.75	-504.61	-579.06	-669.14	17.17	333.41
Treasury Stock	-	-	-	-	-51.22	-51.22
Comprehensive Income & Other	-3.29	-3.29	-2.52	5.55	4.53	1.01
Total Common Equity	1,647	1,570	1,496	1,414	2,099	2,412
Minority Interest	22.44	20.9	11.74	9.25	41.42	57.52
Shareholders' Equity	1,669	1,591	1,508	1,423	2,141	2,470
Total Liabilities & Equity	2,454	2,276	2,628	2,701	3,102	3,798
Total Debt	67.42	61.94	291.36	432.93	327.86	335.8
Net Cash (Debt)	275.51	54.74	-31.39	-186.54	-182.71	57.87
Net Cash Growth	121.04%	-	-	-	-	-10.84%
Net Cash Per Share	0.56	0.11	-0.06	-0.38	-0.37	0.13
Filing Date Shares Outstanding	489.49	489.49	489.49	489.49	489.49	489.49
Total Common Shares Outstanding	489.49	489.49	489.49	489.49	489.49	489.49
Working Capital	841.49	733.71	638.67	706.65	1,252	1,539
Book Value Per Share	3.36	3.21	3.06	2.89	4.29	4.93
Tangible Book Value	1,553	1,474	1,402	1,316	2,003	2,312
Tangible Book Value Per Share	3.17	3.01	2.86	2.69	4.09	4.72
Buildings	724.01	724.01	728	740.85	744.18	747.38
Machinery	166.21	165.14	161.58	162.29	162.16	157.73
Construction In Progress	-	-	-	-	-	1.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.